v3.24.3
Nature of the Business and Basis of Presentation (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Liquidity                  
Accumulated deficit $ (512,255)           $ (512,255)   $ (477,950)
Net Income (Loss) (12,693) $ (3,908) $ (17,704) $ (13,855) $ 14,972 $ (12,270) (34,305) $ (11,153)  
Cash provided by operations             6,919 8,976  
Cash, cash equivalents and short-term investments 223,780           223,780    
Inventory                  
Cost of goods sold 20,109     9,088     $ 43,014 23,823  
Share Based Compensation                  
Expected dividend yield             0.00%    
Clinical supply agreement                  
Inventory                  
Cost of goods sold $ 7,522     $ 1,225     $ 12,462 $ 1,716